Special Report
COVID-19’s Effects on the Brain
COVID-19’s Effects on the Brain
Autopsy studies have yet to find clear evidence of destructive viral invasion into patients’ brains, pushing researchers to consider alternative explanations of how SARS-CoV-2 causes neurological symptoms.
COVID-19’s Effects on the Brain
COVID-19’s Effects on the Brain

Autopsy studies have yet to find clear evidence of destructive viral invasion into patients’ brains, pushing researchers to consider alternative explanations of how SARS-CoV-2 causes neurological symptoms.

Autopsy studies have yet to find clear evidence of destructive viral invasion into patients’ brains, pushing researchers to consider alternative explanations of how SARS-CoV-2 causes neurological symptoms.

infectious disease
Pregnant COVID-19 Patients
Pregnant COVID-19 Patients
The Scientist Staff | Jan 11, 2021
See a news report on a study of expectant mothers with SARS-CoV-2 infections.
Human Fetuses Can Contract SARS-CoV-2, but It’s Rare
Human Fetuses Can Contract SARS-CoV-2, but It’s Rare
Ashley Yeager | Jan 1, 2021
Compared with Zika and cytomegalovirus, the virus that causes COVID-19 appears to have a harder time penetrating the placenta and moving to a woman’s unborn baby.
Infographic: How SARS-CoV-2 Might Travel from Mom to Fetus
Infographic: How SARS-CoV-2 Might Travel from Mom to Fetus
Ashley Yeager | Jan 1, 2021
The virus rarely spreads from mother to child before birth, but it can—and researchers are starting to investigate the path it takes.
The Brain on COVID-19
The Brain on COVID-19
The Scientist Creative Services Team | Dec 21, 2020
Connecting the dots between COVID-19 and neurological disorders
Peering into the Cell<br>
Peering into the Cell
The Scientist Creative Services Team | Dec 16, 2020
Researchers visualize the beautiful inner world of cells!
T Cells: A New Hope for Lasting Protection against SARS-CoV-2
T Cells: A New Hope for Lasting Protection against SARS-CoV-2
The Scientist Creative Services Team | Dec 15, 2020
Alessandro Sette and Shane Crotty discuss the T cell response to SARS-CoV-2 and the implications for vaccine design and robust immune memory.
Opinion: Emergency Use Authorizations Are a Threat to Science<strong>&nbsp;</strong>
Opinion: Emergency Use Authorizations Are a Threat to Science 
Kevin J. Tracey, Christina Brennan | Dec 1, 2020
As COVID-19 therapies get emergency-use green lights, the Biden administration must organize a therapeutic review board to help identify what’s working and what’s not.
Immunity to SARS-CoV-2 Lasts at Least Six Months, Data Show
Immunity to SARS-CoV-2 Lasts at Least Six Months, Data Show
Ashley Yeager | Nov 23, 2020
Half a year after infection, people who had recovered from COVID-19 had robust antibodies, along with traces of the virus in their gut, which may drive long-lasting immunity.
Mosquitos in Asia and the Americas More Susceptible to Zika Virus
Mosquitos in Asia and the Americas More Susceptible to Zika Virus
Abby Olena | Nov 19, 2020
A study explains how Zika was present among mosquitoes in Africa for decades without causing the harm to human health seen outside the continent in recent years.